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Synthetic mimetics of protein secondary
structure domains
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Department of Chemistry, Yale University, PO Box 20810, New Haven,
CT 06520, USA
Proteins modulate the majority of all biological functions and are primarily composed of
highly organized secondary structural elements such as helices, turns and sheets. Many
of these functions are affected by a small number of key protein–protein contacts, often
involving one or more of these well-deﬁned structural elements. Given the ubiquitous
nature of these protein recognition domains, their mimicry by peptidic and non-peptidic
scaffolds has become a major focus of contemporary research. This review examines
several key advances in secondary structure mimicry over the past several years,
particularly focusing upon scaffolds that show not only promising projection of functional
groups, but also a proven effect in biological systems.
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1. Introduction
One of the fundamental tenets of biology is that protein structure dictates protein
function. Within the context of chemical biology, small molecule mimetics of
protein structures are often sought to recapitulate key protein contacts while
taking advantage of the chemical properties inherent to synthetic molecules.
Furthermore, these structural mimetics must be capable of modulating the
interaction between their proteinaceous predecessor and its natural binding
partner. In this sense, just as protein structure dictates protein function, the
ability of the synthetic molecule to mimic a given protein structure will directly
affect its efﬁcacy in a biological setting.
The predominant manner by which protein functions are controlled in nature
is via protein–protein interactions. These interactions cause the burial of a
large, previously solvent-exposed surface that averages 1600 ± 400Å in size
(Cunningham & Wells 1989; Janin & Chothia 1990). These interactions are
governed by hydrophobic, hydrogen bonding, ionic and van der Waals contacts
between the two protein surfaces. While mimicry of these large surfaces with
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synthetic molecules is challenging, the task has been simpliﬁed by the discovery
of protein hot-spots; areas or groups of residues that confer the majority of
favourable free energy for protein–protein association (Cunningham & Wells
1989). Highly ordered secondary structure motifs, such as the α-helix, β- and
γ-turns, and β-sheets, have all been observed to be critical display scaffolds for
key amino acid residues in protein–protein hot-spots.
A highly active ﬁeld has emerged involving the design of small molecules that
mimic these ordered secondary structure domains and display functionality in
a similar fashion. This review examines several of the most important recent
advances in this arena, focusing particularly upon those that show not only
the ability to mimic protein secondary structure, but also to modulate protein
function in a biological system.
2. α-Helices
The α-helix is the most common secondary structure encountered in proteins
(Pace & Scholtz 1998). As a result, it has been a major target for small
molecule mimicry. Mimetics range from slight derivations of natural peptides
to small molecules that bear little resemblance to an α-helix. Early mimetic
structures suffered from poor pharmacokinetic properties and often lacklustre
binding afﬁnities; accordingly, recent efforts have been directed at resolving
these issues.
(a) Peptoids
One of the most simple and effective means of altering the properties of a
peptide and encouraging a helical structure is to convert it to an analogous poly-
N-substituted glycine, or peptoid (Zuckermann et al. 1992). Peptoids, unlike
peptides, have side chains linked directly to their nitrogen atoms, rather than
to their α-carbon atoms. While this eliminates the inherent chirality found in
peptides, and thus would seemingly negate the possibility of helix formation,
α-helix like structures have been induced via the use of chiral N side chains.
Considerable work on structured peptoids has been reported (Stigers et al. 1999;
Patch & Barron 2002). Several recent key contributions show the potential value
of peptoids as antimicrobial agents, as an artiﬁcial lung surfactant and as mimics
of higher order secondary structure.
Barron and co-workers have recently shown the potency of peptoids as
antimicrobial agents (Chongsiriwatana et al. 2008). While antimicrobial peptides
are well known and highly potent agents, they suffer from low bioavailability
owing to the short half-life imposed by protease degradation. Peptoids avoid this
problem owing to the masking of their amide bond, and subsequent inability
to tightly bind proteases (Miller et al. 1994). Barron constructed peptoids out
of a small library of peptoid monomers (ﬁgure 1). These monomers were tuned
primarily for hydrophobicity, with only one monomer each having a positively
or negatively charged side chain. Compared with two antimicrobial peptides,
pexiganan (Ge et al. 1999) and melittin (Fennell et al. 1968), with respective
minimum inhibitory concentrations (MICs) versus Escherichia coli of 3.1 and
1.6μM, and selectivity ratios (deﬁned as the 10% haemolytic dose divided by the
E. coli MIC) of 24 and 1.3, prepared peptoids had MICs versus E. coli between 3
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Figure 1. N-substituted glycine monomers used for the construction of helical peptoids by the
Barron laboratory. (a) NGlu, (b) NLys, (c) NSpe, (d) Nsna, (e) Nsmb, (f) Nssb, (g) Nrpe
and (h) NHis.
and 30μM and selectivity ratios between 1 and 20. Hence, peptoid compounds,
depending upon exact composition, showed similar potency and cytotoxicity to
natural analogues. The overall hydrophobicity and net charge of these peptoids
were found to have a much greater bearing on their biological effects than the
exact side chains chosen, with more hydrophobic compounds generally being more
potent and less selective, while compounds with a net positive charge had slightly
lower activity but showed greatly reduced cytotoxicity.
In addition to antimicrobials, Barron has also adapted peptoids to function as
analogues of SP-C, a component of lung surfactant, the biomaterial found at the
air–liquid interface of lungs (Brown et al. 2008). Treatment of lung surfactant
maladies currently involves replacement of surfactant with animal-lung-derived
compounds (Notter 2000). This can lead to numerous health complications, such
as poor antigen transfer and supply problems, making a totally synthetic solution
highly desirable. Peptoids were prepared from the same pool of monomers as those
designed as antimicrobial agents. Studies showed that the ability of peptoids
to mimic SP-C was derived primarily from the degree of helicity and overall
hydrophobicity, either of which had a much greater impact upon the biological
activity of the peptoid than did the exact side chains chosen at any given position.
The length of the peptoid helical regions was also found to play an important role,
with a peptoid having a 28Å long helix being best able to anchor in the lipid ﬁlm
of lung surfactant. Interestingly, these studies both suggest that peptoids, while
able to mimic the general shape of peptides, may not make the same interactions
with the target, as side-chain selection should bear much more inﬂuence over
observed biological activity.
Zuckermann has taken a different approach to highly structured peptoid
formulation. Rather than attempting to target an α-helix binding site, he
mimicked larger super-structure motifs found in proteins (Lee et al. 2008).
Recently, he adapted a two-helix peptoid bundle, with helices linked by a poly-
glycine loop, to bind zinc atoms. Using very simple helices, but adding thiol and
imidazole groups at select positions, Zuckermann was able to bind zinc atoms
with apparent Kd values as low as 0.3nM (ﬁgure 2).
Phil. Trans. R. Soc. A (2010)992 N. T. Ross et al.
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
NH2
NH2
O
HO
O
HO
NH2
NH2
HO
O
SH SH
NH2
HO
O
O2N
OH
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
NH
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
OH
O NH2
NH2
OH
O
OH
O NH2
N
HN
OH
O NH2
HN O
NH2
Zn
NH
N
O
12-Gly loop
Figure 2. Cysteine and histidine mimetic peptoids bind to a zinc atom, bringing two helices
into a bundle.
The length of the linker between the two helices was found only to matter when
it was too short to allow optimal zinc coordination. These results demonstrated
that peptoids can be used not only to mimic α-helices, but also to mimic higher
order helical systems. However, most peptoid research aims to mimic only random
coil peptides, not peptides with well-deﬁned secondary structures, leaving the
arena wide open for further developments.
(b) β-Peptides
Another important class of biomimetics that can be made to adopt a helical
conformation are β-peptides. These structures are generally composed of β3-
amino acids and adopt a 14-helical structure under most conditions, although
they can also be tailored to form 10/12 or 12 helicies (Kritzer et al. 2005).
In addition, owing to their non-standard backbone sequence, they are resistant
to most proteases that degrade common α-peptides (Frackenpohl et al. 2001).
While early research into β-peptides revolved around synthesis and preliminary
biological evaluation (Cheng et al. 2001), recent work has focused on higher order
β-peptide assembly and more complex biological applications.
The Schepartz group has studied how β-peptides assemble in aqueous solution
and how the residue composition can dictate their higher order assembly into
protein-like macromolecular bundles. The ﬁrst X-ray crystal structure of a
β-peptide bundle showed the role of the hydrophobic edge of the β-peptides
in clustering at the core of an octomeric bundle (Daniels et al. 2007). More
recently, a second structure has been published also displaying an octomeric
overall structure (Goodman et al. 2007). In this case, the hydrophobic core
was maintained, but in addition a network of intramolecular hydrogen bonds
was proposed on the exterior of the octomeric bundle (ﬁgure 3). This work
also detailed a thorough biophysical analysis of these bundles, conﬁrming their
octomeric structures in solution. In addition, Schepartz has been able to regulate
the tertiary assembly of these bundles by varying the side-chain composition. In
one report, a smaller tetrameric bundle was generated (Goodman et al. 2008),
whereas in a second a previously octameric bundle was re-engineered into a
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Figure 3. Structural insights into the assembly of β-peptides can be gained from X-ray crystal
structures depicting the three-dimensional structure of fully assembled β-peptides such as this one
from Goodman et al. (2007).
tetramer using a β3-glycine–β3-glycine linker (Petersson & Schepartz 2008). These
higher order bundles all have molecular weights of the order of 10kDa, making
them viable for consideration as full-size protein mimetics.
To further probe the biological efﬁcacy of β-peptide-based structures the
Schepartz and Gellman groups have both pursued a number of important
biological targets. Schepartz has effectively shown that a β-peptide can mimic
p53 and bind to hDM2 in the p53 binding cleft (Kritzer et al. 2004). In a second
study, they have also shown that β-peptides can be rationally designed to target
gp41 and inhibit HIV-1 cell fusion (Stephens et al. 2005). Gellman and co-workers
have also established biological activity in their β-peptides, targeting both human
cytomegalovirus (HCMV) entry (English et al. 2006) and herpes simplex virus
type-1 (HSV) (Akkarawongsa et al. 2008). In preventing HCMV, β-peptides were
designed to mimic the gB glycoprotein heptad repeat (HR) and block cell fusion
in a similar mechanism to those designed by Schepartz for HIV-1. However, those
targeting HSV are cationic, cell permeable, and appear to impose their anti-HSV
effect at the post-attachment step in HSV infection.
(c) Stapled peptides
Slight modiﬁcations of normal peptide sequences can have profound effects
upon their ability to accurately mimic various secondary structure elements.
One example of this effect is seen in the so-called peptide stapling. In many
cases, short peptide sequences, even those found in the middle of a highly stable
α-helix in a protein, are unable to achieve a helical conformation alone (Baldwin
1995). This is presumably due to entropic penalties, as a disordered chain of
residues is entropically favoured over a well-ordered chain (Creamer & Rose 1992;
Aurora et al. 1997). Peptide stapling overcomes this problem by covalently linking
residues which should be on the same face of a helix, reducing the maximum
length between the two and making helical formation more likely. Recent work
by the Walensky, Cowburn, Verdine and Fairlie groups has shown how promising
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Figure 4. Walensky stapled peptide, which had increased afﬁnity for Bcl-2 over comparable
unstapled compounds.
this technique can be by preparing stapled peptides active versus the Bcl-2
family of proteins, the HIV-1 capsid protein, hDM2 and respiratory syncytial
virus (RSV).
Bcl-2 proteins are a family of apoptosis governors, key regulators of the cell
cycle. The Bcl-2 homology domain 3 (BH3) is a helical region that activates
pro-apoptotic functions of Bcl-2 members. Walensky has designed mimics of
several such helices, each stabilized via addition of an oleﬁn-capped propyl chain
to each of two residues not involved in Bcl-2 binding, followed by subsequent
ruthenium-catalysed oleﬁn metathesis (ﬁgure 4). These compounds were tested
for binding afﬁnity towards Bcl-2 proteins via numerous methods, including
ﬂuorescence polarization (testing direct binding of the helix to a target protein),
liposomal release assay (which models a simpliﬁed mitochondrial system) and a
mitochondrial cytochrome C release assay (in which mitochondria are isolated
from other cellular material and assayed). In each case, the stabilized version
of a peptide showed superior binding compared with the unstabilized analogue
(Bird et al. 2008).
In addition, Walensky showed that stabilized helices exhibited favourable
biophysical properties. Circular dichroism established that ‘stapled’ peptides did
exhibit more helical character (approx. 80% helicity) than unlinked peptides
(approx. 15% helicity). Owing to the forced α-helix conformation, the peptide
chains had fewer exposed peptide bonds and showed resiliency against
proteases. Interestingly, stabilized helices were found to exhibit increased cell
permeability, possibly owing to the helical nature of the peptides (similar to
transmembrane proteins) and the hydrophobic character of the hydrocarbon
staples (Pitter et al. 2008).
Stapled peptides have been targeted to other proteins, such as HIV-1 capsid,
a symmetric dimeric protein which plays a vital role in the formation of HIV
viral particles (Bhattacharya et al. 2008). Cowburn’s NYAD-1, a stapled 12-mer
peptide, exhibited a Kd of 10μM versus capsid. In order to increase aqueous
solubility, NYAD-13 was developed, in which a C-terminal proline was replaced
with three lysine residues. This increased solubility allowed the determination of
the NMR solution structure of the peptide and protein (ﬁgure 5). Though the
interaction between the stapled peptide and protein target is composed primarily
of hydrophobic contacts, the hydrophobic staple is not involved in binding, but
unfavourably exposed to solvent.
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Figure 5. NMR solution structure of a stapled peptide (orange) bound to capsid (blue). The staple
region (green) does not interact with the protein binding site.
Verdine recently used stapled peptides to target the p53/hDM2 interaction,
an important regulatory element in the apoptotic pathway governed by a 15-
mer helical segment of p53 (Bernal et al. 2007). In an initial library derived
from the p53 wild-type sequence, binding afﬁnities for hDM2 as low as 0.9nM
were observed. However, members of this original series were negatively charged
and unable to penetrate Jurkat T-cells. To effect cell penetration, new stapled
peptides with positive charges were prepared. While some potency was lost, the
best compound still exhibited 55nM binding afﬁnity, was cell permeable and
importantly was able to restore apoptotic activity in compromised cells, unlike the
wild-type peptide.
In another use of staple-based mimetics, the Fairlie group has developed an
interesting, rationally designed, bi-cyclic peptide that is capable of adopting a
highly α-helical structure in aqueous solution and disrupting RSV cell fusion
(Shepherd et al. 2006). This 13-mer is made of up two ﬁve-residue cyclic rings
with three linear peripheral residues and is based upon a portion of the HR
C-terminal (HR-C) helix of the RSV F glycoprotein. This surface protein is a
trimer of F1 and F2 dimer units. The F1 portion contains an α-helical HR-C and
HR-N-terminal region. In order for cell fusion to occur, the HR-C region must
undergo a conformational change and fold back upon the HR-N region of F1.
The design principle of this research was to mimic a portion of the HR-C and
inhibit binding to HR-N, which was predicted to affect viral cell fusion. Original
peptide designs were based directly upon the sequence of HR-C that was known
to interact with HR-N from the crystal structure of the post-conformational
change form of F1 (Shepherd et al. 2006). A 13-residue core sequence was selected
(483-FPSDEFDASISQV-495), of which residues F483, F488, I492 and V495 were
observed to interact directly with HR-N (ﬁgure 6). To constrain this sequence,
Fairlie and co-workers looked to the solvent-exposed residues and made selected
point mutations, S485K, A490K, Q494D. This mutant peptide could then be
constrained by making two K(i) to D(i + 4) lactam bridges, and was found to
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Figure 6. Peptide sequences used by Shepherd et al. (2006). Key interacting residues are indicated
in dark grey, mutated residues that allowed for lactam constraints are light grey.
be highly α-helical by circular dichroism. This constrained bi-cyclic peptide has
a root mean square deviation (RMSD) overlay of backbone atoms of HR-C of
0.99Å, and was found to inhibit cell fusion with low nanomolar IC50 values.
The peptide also had antiviral activity against RSV, which reduced RSV plaque
number in a dose-dependent fashion, with an IC50 of 36nM. This activity is much
greater than the full length HR-C peptide, which had been previously shown to
reduce RSV plaques with an IC50 of 2.93μM.
These studies have shown the power of peptide stapling as a method to turn
simple peptides into well-folded, biologically active compounds. As the approach
develops, it is likely that the staples themselves may be integrated into binding
schemes and become more than mere structure modulators.
(d) Small molecules and assemblies
Apart from the generally peptidic structures above, numerous non-peptidic
small molecules have been developed to mimic α-helicies. Early contributions
from Hamilton and co-workers showed that a terphenyl scaffold was capable of
projecting functionality in a similar manner to the i, i + 3 (or i + 4) and i + 7
residues of an α-helix (Orner et al. 2001). Since then, efforts have been exerted to
design similar teraryl molecules, and several reviews on these molecules have been
published (Yin & Hamilton 2005; Davis et al. 2007). In light of this, we only aim
to cover structures that have been reported within the last two years. A driving
force in the recent literature has been the desire to decrease overall compound
hydrophobicity as well as reduce the synthetic complexity of teraryl-based α-helix
mimetics. This has been accomplished either by increasing the heteroaromatic
nature of the core aryl units (ﬁgure 7, compounds 3–10) or by replacing some
of the covalent character of the scaffold with a hydrogen bonding aromatic ring
isostere (ﬁgure 7, compounds 1, 2).
The structure of a 5-6-5 imidazole-phenyl-thiazole scaffold (3)( Cummings et al.
2009) bearing additional heteroaromatic functionality has recently been reported.
Rebek and co-workers have also published a series of pyridazine-based scaffolds
(4–8) with a variety of aromatic and heteroaromatic peripheral groups (Biros
et al. 2007; Volonterio et al. 2007). Additionally, two piperazine based scaffolds
(9, 10) have been reported, one by Konig (10) incorporating two peripheral
piperazine units with a central benzene core (Maity & Konig 2008), and a second
by Rebek (9), with one central piperazine unit with peripheral benzene units
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Figure 7. Recent α-helix mimetics from the Hamilton (1–3), Rebek (4–9) and Konig (10) groups.
(Restorp & Rebek 2008). Both display functional groups in a manner to mimic
three or four α-helicial side-chain positions. We have recently shown that hydrogen
bonding functional groups such as an enaminone (2)( Rodriguez & Hamilton
2006) or benzoylurea (1)( Rodriguez & Hamilton 2007) can replace a central six-
membered ring, reducing hydrophobicity and synthetic complexity of these types
of scaffolds.
Another noteworthy advance has been the incorporation of stereocentres into
the teraryl-based α-helix mimetics. The original Hamilton terphenyl molecules,
while mimicking a chiral α-helix, are themselves achiral. However, Rebek and
Konig have now incorporated one and two stereocentres, respectively, into their
mimetics (4–8, 10). While potentially adding to the synthetic complexity of helical
mimetics, the presence of stereogenic chiral centres may eventually be important
in protein binding studies.
In later work, we have addressed elongation of these scaffolds to the mimicry
of three or four side-chain positions, as well as addressing new biological
targets beyond Bcl-xL/Bak and p53/MDM2. We have recently shown that
a benzoylurea scaffold (1) can be elongated to mimic as many as nine side
groups of an α-helix; a compound that when fully elongated spans almost 40Å
(Rodriguez & Hamilton 2007)
Using the 5-6-5 imidazole-phenyl-thiazole scaffold (3), we have generated the
ﬁrst rationally designed, small molecule inhibitor of the interaction between
the GTPase Cdc42 and its associated guanine nucleotide exchange factor Dbs
(Cummings et al. 2009)w i t ha6 7μMI C 50 (ﬁgure 8). Like previous helix mimetics,
these were designed to mimic the i, i + 4 and i + 7 positions of a target α-helix;
in this case, Q770, K774 and L777 of Dbs. However, when compared with earlier
generations of mimetics, these possess signiﬁcantly increased solubilities. The
calculated log P (o/w) values of trimethyl-substituted terphenyl and terpyridine
compounds are 7.3 and 3.4, respectively, while that of the trimethyl 5-6-5
imidazole-thiazole-phenyl compound is 2.3.
Although most biomimetic efforts have been devoted to the α-helix, this is
not the only type of helical molecule found in nature. Several types of helices,
including α-helices, 310 helices, pi helices and double helices are found in peptides
and DNA. Likewise, other areas of chemistry have found a use for modiﬁed helices.
One such area has been investigated by Pepitone, who used a supramolecular
helical scaffold to model photosynthetic properties (Kim et al. 2008). In nature,
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Figure 8. (a) Overlay of the X-ray crystal structure of a trismethyl 5-6-5 imidazole-phenyl-thiazole
derivative with key contact residues from Dbs. (b) Inhibition data of 5-6-5 compound, which
displayed a 67μMI C 50 value against the Cdc42/Dbs interaction as measured by the ability to
disrupt Dbs assisted uptake of mantGDP by Cdc42.
Figure 9. A superhelix antenna array. A DASP chromophore (white rod) is encapsulated by a helix
(dark grey) with the assistance of CMA aggregates (light grey ovals).
chlorophyll molecules are often used as light harvesting antennae, and are
arranged in circular formations about photoreactive centres. This arrangement
has been modelled by a helical scaffold wrapped around a central, rod-like
photoacceptor core.
Pepitone used polycarboxymethyl amylose (CMA) with 6 per cent to 100
per cent of amylose units carboxymethylated (the DS value of the polymer).
While CMA did not form a helical structure alone, addition of one of three
dyes, a cyanine-based light harvesting dye or a rodlike acceptor dye (4-(4-
(dimethylamino)styryl)-1-alkylpyridinium bromide (DASP)-C22 or DASP-6V12),
led to helix formation. Subsequent addition of the complementary dye completed
the antenna ensemble (ﬁgure 9). Regardless of the order of dye addition to the
CMA polymer, the acceptor was wrapped on the inside of the helix and the
cyanine dye studded the helix’s surface.
These superhelices act as excellent electron transfer systems. A quenching
efﬁciency of greater than 90 per cent was observed when the cyanine dye molecules
are excited, which compares well with the nearly 100 per cent efﬁciency in natural
photosynthetic systems. Similarly, the ﬂuorescence lifetime of the donor was seen
to decrease ﬁvefold when placed in this system, suggesting rapid and stable
quenching by the DASP dyes. These two properties suggest that the antenna
system works as an effective system for artiﬁcial photosynthesis.
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Figure 11. (a) Generic spyrocycle scaffold for β-turn mimicry. (b) Optimal MC4R agonist
developed.
3. Turn structures
In addition to α-helices, organized turn motifs are among the most well-studied
secondary structural features of proteins. These turns generally involve three
to ﬁve amino acids, and impose well-deﬁned phi and psi angles not otherwise
available to helices, sheets or extended peptide sequences. Seminal work from the
Robinson (Robinson 2008; Robinson et al. 2008), Mayo (Dings & Mayo 2007) and
Nowick (2008) laboratories on turn mimicry has recently been reviewed.
An intriguing example of a fully synthetic turn inducing scaffold comes from
Albericio et al. (2008), who described the synthesis of a novel trishomocubane
amino acid (ﬁgure 10) used in the centre of the hexa-alanine polypeptide to
generate a (Ala)3-cage-(Ala)3 heptapeptide. Following HPLC puriﬁcation of
diastereomers, structures of the two peptide forms were determined using X-ray
crystallography and their structural characteristics were examined. The alanine
residues on either side of the trishomocubane amino acid adopt a 310-helical
conformation and the cubane itself, in either diastereomeric form, is capable of
causing a β-turn between these two short sections of helix. This trishomocubane
amino acid serves as a novel covalent method for inducing β-turns in peptide
chains and could potentially be employed with other, non-alanine, amino acids
in an effort to generate β-sheet-type secondary structures.
A common theme among turn inducing scaffolds is the use of spirocycles,
owing to their ability to mimic the orientation of bonds at the α-carbon of
an amino acid involved in a β-turn. Li recently made use of a non-peptidic
spyrocycle (ﬁgure 11a) to mimic agonists of MC4R, a melanocortin family
G-protein-coupled receptor known to bind peptides in a β-turn conformation
(Webb et al. 2007). Interestingly, this scaffold was designed using cluster analysis
principles pioneered by Garland & Dean (1999), which allow for the rapid
searching of structural databases to locate scaffolds that position atoms in a
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Figure 12. (a) An azobenzene turn inducer as a trans-isomer. The attached residues are spread
out. (b) An azobenzene turn inducer as a cis-isomer. The attached residues form a β-turn.
similar manner to a peptidic β-turn. Following combinatorial exploration, an
inhibitor with an EC50 of 0.7μM versus MC4R was developed (ﬁgure 11b). Several
of the compounds also showed encouraging selectivity for MC4R relative to other
melanocortin and β-turn binding receptors, suggesting that the scaffold might
eventually evolve into a highly selective binding agent.
One particularly well-investigated system involving a β-turn is somatostatin, a
decapeptide hormone with a critical binding region comprising Phe-Trp-Lys-Thr
in a β-turn motif. This hormone, which downregulates the release of numerous
other hormones, is of interest for drug intervention. However, many turn mimetics
do not mimic amino acid side-chain functionality, rendering them less useful in
this system, where the turn is also the recognition sequence.
Ulysse & Chmielewski (2006) have bypassed this problem with the construction
of a cyclic peptide employing an azobenzene monomer opposite the tetrapeptide
binding region. This allows both for the instigation of turn formation at the
critical four residues and for light-modulated activation or deactivation of
the peptide (ﬁgure 12).
When tested for binding against the somatotropin release-inhibiting factor
receptor, a natural somatostatin target, the β-turn inducing cis-isomer was found
to have a Ki of 1.0 ± 0.1μM, modestly improved relative to the 2.6 ± 0.2μMo f
the trans-isomer. Both isomers showed a Ki superior to that of a linear peptide
analogue (Ki =16 ± 2μM). This encouraging result suggests that azobenzene can
not only act as a β-turn for attached peptides, but also modulate drug activity.
While novel developments in covalent methods for linking peptide chains to
form stable β-sheet structures have been discussed, there has also been recent
progress in non-covalent methods for orienting peptide strands. The Kraatz group
have used ferrocene to coordinate two cyclopentadienyl rings attached to separate
tripeptide strands (Chowdhury et al. 2008). Unlike previous efforts, a glycine
residue was chosen at position R1 on each strand (ﬁgure 13). This selection took
advantage of the high degree of phi and psi angles accessible to the glycine
backbone to help facilitate cross-peptide-strand hydrogen bonding.
This work represents a signiﬁcant advance over previous ferrocene amino
acid conjugates where either peptide monomers (Henrick et al. 1996) or dimers
(Moriuchi et al. 2001) have been used. Other research into this area has focused
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Figure 13. The use of a ferrocine tethered between two cyclopentadienyl terminated amino
acid chains that feature a Gly-X-X motif allowing for β-sheet formation with cross-strand
hydrogen bonds.
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Figure 14. Metal tethered phosphine-based turn mimetic developed by Laungani et al. (2008).
on the attachment of the peptides to the cyclopentadienyl core to generate either
‘parallel’ or ‘anti-parallel’ strands (Barisic et al. 2004; Chowdhury et al. 2005).
The most recent report from the Kraatz group detailed the generation of β-helices
(Chowdhury et al. 2006) and these efforts have now been extended to β-sheets.
In addition, unlike some previous reports using both covalent and non-covalent
coordination methods, researchers have now been able to maintain the β-sheet
conformation beyond two residues, demonstrating a more complete β-sheet.
Another recent advance in the area of metal-chelation-driven assembly comes
from the Breit group (Laungani et al. 2008) where platinum or rhodium was
used to coordinate two diphenylphosphine ligands tethered to short peptide
fragments. In several reports, the Breit group detailed the use of DNA A–
T base pairing to discover new catalysts for the hydroformylation of terminal
alkenes (Breit & Seiche 2003; Waloch et al. 2007). They have also described
the discovery of self-assembled bi-dentate ligands for ruthenium-catalysed anti-
Markovnikov hydration of terminal alkenes (Chevallier & Breit 2006)a sw e l l
as for asymmetric rhodium-catalysed hydrogenation (Weis et al. 2006). More
recently, they reported the attachment of one amino acid to their phosphine-based
ligand binding compounds to impart greater catalyst speciﬁcity (Laungani &
Breit 2008). All of these reports have hinged upon hydrogen bonding between
two ligands of the bi-dentate metal binding pair.
This work has now been further extended to incorporate two amino acids along
with a pyridine or phenyl ring, which are capable of intermolecular hydrogen
bonding when properly aligned by metal chelation (ﬁgure 14). Prior to this
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work Schneider & Kelly (1995) chelated copper to a single peptide strand to
help induce a β-sheet-type structure, and more recently Kruppa et al. (2005)
used a peptide strand appended with zinc to coordinate a second peptide
strand and form a β-sheet structure. The current approach used by Laungani
et al. (2008) relies on a three-component system where the phenyl–peptide,
pyridinyl–peptide and metal come together in a combinatorial fashion. This
self-assembly was used to discover a novel catalyst for asymmetric rhodium-
catalysed hydroformylation. Additionally, this process could easily be adapted to
a dynamic combinatorial library (Rozenman et al. 2007) directed at the discovery
of novel β-sheet protein mimetics.
4. Coil-based structures
Thus far, we have considered attempts to mimic only the most regularly
encountered secondary structural motifs exhibited by biomacromolecules.
However, some proteins participate in protein–protein interactions via so-called
‘random coil’ sequences. Such conformations are not at all random, however, and
are ordered for any given system. While considered less systematically than other
peptide structures, mimicry of such random coils can prove very promising. The
emerging importance of the second mitochondrial activator of caspases (Smac)
helps to exemplify this promise.
Apoptosis is a highly regulated cellular process that is at the centre of
essentially all types of cancer. X-linked inhibitor of apoptosis (XIAP) is one
of a family of IAP proteins that is known to be an inhibitor of apoptosis via
its interaction with caspases. The speciﬁc interaction between the baculoviral
IAP repeat (BIR) domain of XIAP and caspase-9 disrupts the ability of the
caspase to adopt its active homodimeric conformation (Shiozaki et al. 2003). This
disruption is conferred by the interaction of the BIR domain with the four N-
terminal residues (Ala-Thr-Pro-Phe) of caspase-9. To alleviate this suppression,
the second mitochondrial activator of caspases (Smac) is released from the
mitochondria upon pro-apoptotic activation and, with its own four N-terminal
residues (Ala-Val-Pro-Iso (AVPI)), competes for binding of the BIR domain
of XIAP, releasing bound caspase-9 (Srinivasula et al. 2001). Based upon this
information, Zobel et al. (2006) proposed that Smac AVPI mimetics would likely
elicit a pro-apoptotic response in cells.
The four terminal residues of Smac are known to exist in a random coil
conformation based upon X-ray crystallographic results (ﬁgure 15; Wu et al.
2000; Vucic et al. 2005; Zobel et al. 2006). In previous work, the Deshayes
group had also determined via phage display that the afﬁnity of a peptidic
4-mer for the BIR domain was increased if the sequence was altered to Ala-
Val-Pro-Trp (AVPW; Franklin et al. 2003). Zobel et al. (2006) solved the X-ray
crystal structure of AVPW bound to the BIR domain and found that it adopted
a coil conformation highly similar to that of larger Smac peptides (RMSD
Cα =0.115Å). However, AVPW has no biological activity and consequently a
less peptidic compound was sought that would maintain the contacts made
by AVPW. Progressively less peptidic compounds were screened where 11
(ﬁgure 16a) was found to inhibit the BIR–Smac interaction with an inhibition
constant (Ki)o f1 5 μM. This then was further modiﬁed to 12 (Ki =1μM),
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Figure 15. X-ray crystal structure of Smac (blue/black) bound to XIAP-BIR domain
(orange/magenta), AVPI residues of Smac are shown in green (pdb 1G73; Wu et al. 2000).
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Figure 16. Structures of Zobel et al. (2006) compounds. Compounds (a) 11,( b) 12 and (c) 13
depicting the evolution of Smac mimetics from more to less peptidic compounds.
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Figure 17. Initial lead compounds from the Deshayes group: (a) AVPW and (b) the ﬁnal inhibitor
13, both bound to a BIR domain as found in XIAP.
and ﬁnally 13, which disrupted the interaction with 20-fold higher potency
(Ki =50nM). X-ray crystallographic analysis demonstrated that 13 bound the
BIR domain in the same conformation as the AVPW peptide (ﬁgure 17). However,
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Figure 18. Smac mimetics from the Wang group, where dimerization of Smac mimetics has been
shown to be an effective means of increasing compound potency and efﬁcacy.
unlike AVPW, 13 was found to have activity in vitro and was also capable
of protecting both breast cancer and melanoma cells by causing increased
apoptosis.
The Wang group has expanded upon this area of mimetic research by
generating both linear (Sun et al. 2007) and cyclic (Nikolovska-Coleska et al.
2008) bivalent Smac mimetics that bind to BIR domains, as in XIAP. In the
case of their linear mimetics (ﬁgure 17) Sun and co-workers were able to realize
a 300-fold increase in binding afﬁnity against targets containing both a BIR2
and a BIR3 domain when compared with the monovalent inhibitor counterparts
(IC50 =1.39nM versus 417nM). In the case of their more constrained cyclic
bivalent derivative, a 22-fold improved activity over the monovalent version
is observed (Ki =4nM versus 86nM; ﬁgure 18). Additionally, a co-crystal
structure of bivalent 17 with the BIR3 domain of XIAP depicts 17 cross-
linking two monomeric units of XIAP, helping to explain its potency. Ultimately,
in both the linear and the cyclic systems, these compounds proved effective
modulators of XIAP function both in vitro and in cell-based models for
multiple cancers and provide compelling examples for the use of multivalent
inhibitors.
5. Conclusions
We have herein highlighted several advances in the area of protein secondary
structure mimetics. In particular, we have focused on molecules that are able
to project functionality in the same fashion as a protein and have validated
activity against biological targets. The drive to expand libraries and improve
the pharmacological properties of compounds suggests that the ﬁeld is ripe for
ground-breaking mimetic scaffolds targeting the important secondary structure
elements involved in so many key biological processes.
We would like to thank the National Institutes of Health (GM35208 and CA67771) for their
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